JTL Industries Limited (NSE:JTLIND)

Sage Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	773.03	1,012	500.85	2.59	2.12
Cash & Short-Term Investments	773.03	773.03	1,012	500.85	2.59	2.12
Cash Growth	-27.08%	-23.64%	102.11%	19275.28%	21.76%	-60.63%
Accounts Receivable	-	2,799	1,927	1,412	1,096	951.13
Other Receivables	-	-	218.56	-38.95	131.64	131.58
Receivables	-	3,728	2,561	1,670	1,272	1,084
Inventory	-	2,174	1,504	1,677	1,193	530.87
Prepaid Expenses	-	-	0.66	0.68	1.01	2.78
Other Current Assets	-	3,039	1,513	884.36	112.75	175.48
Total Current Assets	-	9,715	6,592	4,733	2,581	1,796
Property, Plant & Equipment	-	2,849	1,173	697.63	519.85	284.76
Long-Term Investments	-	102.93	57.95	161.69	124.19	0.14
Other Long-Term Assets	-	724.67	611.82	42.46	167.06	13.39
Total Assets	-	13,391	8,435	5,635	3,392	2,094
Accounts Payable	-	226.22	244.99	286.22	256.98	338.39
Accrued Expenses	-	-	35.8	23.12	23.97	13.31
Short-Term Debt	-	-	-	-	809.45	519.83
Current Portion of Long-Term Debt	-	656.47	200.05	976.48	30.12	4.35
Current Income Taxes Payable	-	19.48	42.87	80.4	29.04	70.58
Other Current Liabilities	-	123.82	124.01	46.68	125.8	39.96
Total Current Liabilities	-	1,026	647.73	1,413	1,275	986.41
Long-Term Debt	-	105.27	-	91.26	103.58	106.97
Long-Term Deferred Tax Liabilities	-	12.09	18.59	41.65	18.81	20.16
Other Long-Term Liabilities	-	61.18	4.31	3.42	6.87	6.09
Total Liabilities	-	1,205	687.33	1,563	1,415	1,125
Common Stock	-	393.08	354.02	168.68	134.45	106.07
Additional Paid-In Capital	-	-	1,672	608.11	392.21	98.43
Retained Earnings	-	-	3,383	2,269	1,358	608.38
Comprehensive Income & Other	-	11,790	2,338	1,025	91.86	156.17
Total Common Equity	12,183	12,183	7,748	4,071	1,977	969.05
Minority Interest	-	3.38	-	-	-	-
Shareholders' Equity	12,186	12,186	7,748	4,071	1,977	969.05
Total Liabilities & Equity	-	13,391	8,435	5,635	3,392	2,094
Total Debt	761.74	761.74	200.05	1,068	943.15	631.15
Net Cash (Debt)	11.29	11.29	812.23	-566.89	-940.56	-629.02
Net Cash Growth	-98.69%	-98.61%	-	-	-	-
Net Cash Per Share	0.03	0.03	2.34	-1.46	-3.59	-2.97
Filing Date Shares Outstanding	388.66	391.13	382.86	337.37	236.75	212.15
Total Common Shares Outstanding	388.66	391.13	354.02	337.37	236.75	212.15
Working Capital	-	8,689	5,944	3,320	1,305	809.13
Book Value Per Share	31.15	31.15	21.88	12.07	8.35	4.57
Tangible Book Value	12,183	12,183	7,748	4,071	1,977	969.05
Tangible Book Value Per Share	31.15	31.15	21.88	12.07	8.35	4.57
Land	-	-	174.33	106.95	62.79	46.12
Buildings	-	-	374.55	158.96	158.96	61.59
Machinery	-	-	874.54	642.13	468.24	224.5
Construction In Progress	-	-	60.05	44.01	34	-

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.